Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
57.95
+2.59 (4.68%)
At close: Mar 6, 2026

SHA:688513 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,10410,7315,2527,6597,3065,572
Market Cap Growth
91.87%104.34%-31.43%4.83%31.12%-2.50%
Enterprise Value
8,6719,2984,0106,4196,1123,987
Last Close Price
57.9561.5529.8442.4840.1130.07
PE Ratio
35.5537.8922.0533.8129.6423.97
Forward PE
33.3036.0716.2125.3322.56-
PS Ratio
7.598.063.896.866.245.45
PB Ratio
3.533.741.952.942.992.43
P/TBV Ratio
3.573.791.972.983.032.47
P/FCF Ratio
--36.0276.60--
P/OCF Ratio
--19.9527.8348.0937.75
EV/Sales Ratio
6.516.982.975.755.223.90
EV/EBITDA Ratio
22.0123.6116.0528.4728.3323.72
EV/EBIT Ratio
27.7529.7523.8142.1738.8329.43
EV/FCF Ratio
--27.5064.19--
Debt / Equity Ratio
0.050.050.040.090.040.01
Debt / EBITDA Ratio
0.340.340.460.990.490.12
Debt / FCF Ratio
--0.782.24--
Net Debt / Equity Ratio
-0.50-0.50-0.48-0.50-0.51-0.65
Net Debt / EBITDA Ratio
-3.64-3.64-5.24-5.76-5.76-8.83
Net Debt / FCF Ratio
---8.98-13.006.6312.11
Asset Turnover
--0.400.350.400.39
Inventory Turnover
--1.971.501.631.56
Quick Ratio
--2.872.572.893.77
Current Ratio
--3.232.853.234.11
Return on Equity (ROE)
10.18%10.18%8.99%8.98%10.41%10.60%
Return on Assets (ROA)
--3.12%2.99%3.40%3.19%
Return on Invested Capital (ROIC)
20.63%20.96%11.80%11.39%14.74%19.36%
Return on Capital Employed (ROCE)
--6.00%5.70%6.30%5.80%
Earnings Yield
2.80%2.64%4.54%2.96%3.37%4.17%
FCF Yield
--2.78%1.31%-2.56%-2.20%
Dividend Yield
0.74%-1.44%0.93%0.95%1.76%
Payout Ratio
--31.11%31.37%38.96%15.66%
Buyback Yield / Dilution
0.80%0.80%1.04%-0.14%-0.37%-19.70%
Total Shareholder Return
1.59%0.80%2.48%0.79%0.58%-17.94%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.